A recent Health Affairs blog post (April 19) on hospital price transparency argues that chargemaster data can be confusing to consumers. We agree, and have encouraged the Department of Health and Human Services (HHS) to focus, instead, on the information that really matters to patients – expected out-of-pocket costs. However, HHS currently requires all hospitals to publish their charges as reflected in their chargemasters.

Hospitals and health systems are working in myriad ways to improve patients’ access to cost information beyond the HHS requirement. For example, Memorial Healthcare System in South Florida provides patients their anticipated out-of-pocket costs for common medical procedures through a consumer-friendly online tool. Others, such as hospitals in HSHS Eastern Wisconsin Division and St. Luke’s University Health Network, have worked with their electronic health record vendors, payers and other partners to develop similar tools.

However, challenges remain. Providing accurate out-of-pocket cost estimates is only feasible for “shoppable” services that are discrete and planned in advance. Estimates are much harder for emergency services and complex care, when a final diagnosis may be unknown or the course of care is likely to change as treatment progresses. Given that patients treated in hospital settings are more medically complex and have more chronic conditions than patients treated in other settings, predicting the cost of services in advance can be more challenging for hospitals.1

Hospitals will continue working to improve patients’ access to information on their anticipated out-of-pocket costs. Moreover, they will work to ensure that patients have access to other information important to making critical health care decisions, including on the quality of their care.


1 KNG Health Consulting LLC. Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical

Centers and Hospital Outpatient Departments. April 4, 2019. https://www.aha.org/system/files/media/file/2019/04/kng-health-aha-analysis-of-hopd-vs-asc-report.pdf

 

 

By Tom Nickels, Executive Vice President of the American Hospital Association

Related News Articles

Headline
The House Energy and Commerce Subcommittee on Health today held a hearing on seven bills aimed at improving transparency in the drug supply chain to lower…
Headline
The Centers for Medicare…
Headline
The largest U.S. pharmaceutical and biotech companies spend just 22 cents out of every dollar on research and development, according to an analysis released…
Headline
The House Ways and Means Committee today approved the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113), AHA-supported…
Headline
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., along with several other Democratic senators, yesterday introduced bills aimed at increasing…
Headline
The Department of Health and Human Services’ Office of Inspector General yesterday proposed excluding from safe harbor protection under the Anti-Kickback…